Competitive intelligence on 
 small-molecule drugs and 
 the 90,000 global patents 
 covering them 

Start your free trial now

DrugPatentWatch Ultimate Plan Preview

Details for Generic Name: ropivacaine hydrochloride

« Back to Dashboard

Summary for Generic Name: ropivacaine hydrochloride

Drug Master File Entries: see list11
Suppliers: see list3

Pharmacology for Ingredient: ropivacaine hydrochloride

Drug ClassAmide Local Anesthetic
Physiological EffectLocal Anesthesia

Clinical Trials for: ropivacaine hydrochloride

Intraperitoneal Ropivacaine Nebulization for Pain Control After Laparoscopic Surgery
Status: Completed Condition: Laparoscopic Cholecystectomy

Ropivacaine Hypobaric Spinal Anaesthesia in Traumatic Hip Surgery
Status: Completed Condition: Femoral Neck Fracture

Intraperitoneal Ropivacaine Nebulization for Pain Control After Gynecologic Laparoscopic Surgery
Status: Completed Condition: Ovarian Cysts

Surgical Pain Control With Ropivacaine by Atomized Delivery
Status: Recruiting Condition: Pain

Routine Irrigation With Ropivacaine vs. Lidocaine vs. Saline of Surgical Bed in Sleeve Gastrectomy
Status: Not yet recruiting Condition: Overweight and Obesity

A Comparison of Ropivacaine Alone Versus Combination of Dexamethasone and Clonidine for Block
Status: Recruiting Condition: Upper Extremity Fracture

A Comparison of Postoperative Analgesic Nerve Block Ropivacaine Concentrations
Status: Active, not recruiting Condition: Total Hip Arthroplasty; Postoperative Pain

Peritoneal Nebulization of Ropivacaine for Pain Control After Laparoscopic Colectomy
Status: Terminated Condition: Postoperative Pain

Effects of Epidurally Administered Ropivacaine Concentration on the Hemodynamic Parameters
Status: Recruiting Condition: Epidural Anesthesia; Ropivacaine Concentration; Hemodynamics

Analgesic Efficacy of Inter Pleural Ropivacaine Road in Post Thoracotomy Pain for Oncologic Surgery
Status: Completed Condition: Postoperative Pain; Cancer

Courtesy of
See more clinical trials for this drug
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa
ropivacaine hydrochloride
INJECTABLE;INJECTION020533Sep 24, 1996RXNo8,118,802<disabled>Y<disabled>
Fresenius Kabi Usa
ropivacaine hydrochloride
INJECTABLE;INJECTION020533Sep 24, 1996RXNo5,670,524<disabled>YY<disabled>
Fresenius Kabi Usa
ropivacaine hydrochloride
INJECTABLE;INJECTION020533Sep 24, 1996RXNo8,162,915<disabled>Y<disabled>
ropivacaine hydrochloride
INJECTABLE;INJECTION090194Sep 23, 2014RXNo<disabled><disabled>
Sagent Strides
ropivacaine hydrochloride
INJECTABLE;INJECTION090318Sep 23, 2014RXNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013   2014  

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2015 thinkBiotech LLC
ISSN: 2162-2639

Preferred citation:

Friedman, Y. Location of pharmaceutical innovation: 2000–2009 Nature Reviews Drug Discovery 9, 835–836 (2010).

Connect with Social Media:

Follow DrugPatentWatch on Twitter
Connect with DrugPatentWatch on Linkedin
Drug Patents on LinkedIn